# Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial

> **NCT06024291** · NA · COMPLETED · sponsor: **University of Basel** · enrollment: 88 (actual)

## Conditions studied

- Overweight and Obesity
- Dyslipidemias
- Blood Pressure
- Cardiovascular Diseases
- Metabolic Disease

## Interventions

- **OTHER:** 8-week HIIT programme
- **OTHER:** Physical activity recommendation

## Key facts

- **NCT ID:** NCT06024291
- **Lead sponsor:** University of Basel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-15
- **Primary completion:** 2025-01-15
- **Final completion:** 2025-01-15
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2025-05-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06024291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06024291, "Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06024291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*